The future of regenerative medicine
Share

The future of regenerative medicine

Ross Macdonald, CEO of Cynata Therapeutics, tells CNBC about how the company has progressed to phase 1 of the clinical trial stage.
01:55
Mon, May 8 201712:43 AM EDT